APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Transient Receptor Potential Cation Channel Subfamily V Member 1

Compare research editions
View pricing & licenses

Selected research

Industry Research

Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Research Report 2026

Report ID 174042740519 December 2025128 pages

Choose your research edition.

Industry ResearchTransient Receptor Potential Cation Channel Subfamily V Member 1 Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Transient Receptor Potential Cation Channel Subfamily V Member 1 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Transient Receptor Potential Cation Channel Subfamily V Member 1 market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Transient Receptor Potential Cation Channel Subfamily V Member 1 market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Transient Receptor Potential Cation Channel Subfamily V Member 1 market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Transient Receptor Potential Cation Channel Subfamily V Member 1 include Amgen Inc, Vitality Biopharma Inc, Toray Industries Inc, Sylentis SAU, Pila Pharma AB, Neurim Pharmaceuticals Ltd, Medifron DBT Co Ltd, Kyowa Hakko Kirin Co Ltd and Grunenthal GmbH, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Transient Receptor Potential Cation Channel Subfamily V Member 1.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Transient Receptor Potential Cation Channel Subfamily V Member 1 Market by Company

Amgen Inc

Vitality Biopharma Inc

Toray Industries Inc

Sylentis SAU

Pila Pharma AB

Neurim Pharmaceuticals Ltd

Medifron DBT Co Ltd

Kyowa Hakko Kirin Co Ltd

Grunenthal GmbH

Flex Pharma Inc

DoNatur GmbH

Daewoong Pharmaceutical Co Ltd

Centrexion Therapeutics Corp

BCN Peptides SA

Amorepacific Corp

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Type

DD-04107

CMX-020

CA-016

Others

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application

Abdominal Pain

Muscle Spasm

Immunology

Pruritus

Ophthalmology

Others

Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transient Receptor Potential Cation Channel Subfamily V Member 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transient Receptor Potential Cation Channel Subfamily V Member 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Transient Receptor Potential Cation Channel Subfamily V Member 1 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2021-2026) Table 7. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Type (2027-2032) Table 9. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2021-2026) Table 11. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Application (2027-2032) Table 13. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2021-2026) Table 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region (2027-2032) Table 18. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends Table 19. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Drivers Table 20. Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Opportunities and Challenges Table 21. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints Table 22. Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2021-2026) Table 24. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Transient Receptor Potential Cation Channel Subfamily V Member 1, Headquarters and Area Served Table 26. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032) & (US$ Million) Table 45. Amgen Inc Company Information Table 46. Amgen Inc Business Overview Table 47. Amgen Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 48. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 49. Amgen Inc Recent Developments Table 50. Vitality Biopharma Inc Company Information Table 51. Vitality Biopharma Inc Business Overview Table 52. Vitality Biopharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 53. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 54. Vitality Biopharma Inc Recent Developments Table 55. Toray Industries Inc Company Information Table 56. Toray Industries Inc Business Overview Table 57. Toray Industries Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 58. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 59. Toray Industries Inc Recent Developments Table 60. Sylentis SAU Company Information Table 61. Sylentis SAU Business Overview Table 62. Sylentis SAU Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 63. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 64. Sylentis SAU Recent Developments Table 65. Pila Pharma AB Company Information Table 66. Pila Pharma AB Business Overview Table 67. Pila Pharma AB Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 68. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 69. Pila Pharma AB Recent Developments Table 70. Neurim Pharmaceuticals Ltd Company Information Table 71. Neurim Pharmaceuticals Ltd Business Overview Table 72. Neurim Pharmaceuticals Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 73. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 74. Neurim Pharmaceuticals Ltd Recent Developments Table 75. Medifron DBT Co Ltd Company Information Table 76. Medifron DBT Co Ltd Business Overview Table 77. Medifron DBT Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 78. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 79. Medifron DBT Co Ltd Recent Developments Table 80. Kyowa Hakko Kirin Co Ltd Company Information Table 81. Kyowa Hakko Kirin Co Ltd Business Overview Table 82. Kyowa Hakko Kirin Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 83. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 84. Kyowa Hakko Kirin Co Ltd Recent Developments Table 85. Grunenthal GmbH Company Information Table 86. Grunenthal GmbH Business Overview Table 87. Grunenthal GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 88. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 89. Grunenthal GmbH Recent Developments Table 90. Flex Pharma Inc Company Information Table 91. Flex Pharma Inc Business Overview Table 92. Flex Pharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 93. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 94. Flex Pharma Inc Recent Developments Table 95. DoNatur GmbH Company Information Table 96. DoNatur GmbH Business Overview Table 97. DoNatur GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 98. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 99. DoNatur GmbH Recent Developments Table 100. Daewoong Pharmaceutical Co Ltd Company Information Table 101. Daewoong Pharmaceutical Co Ltd Business Overview Table 102. Daewoong Pharmaceutical Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 103. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 104. Daewoong Pharmaceutical Co Ltd Recent Developments Table 105. Centrexion Therapeutics Corp Company Information Table 106. Centrexion Therapeutics Corp Business Overview Table 107. Centrexion Therapeutics Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 108. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 109. Centrexion Therapeutics Corp Recent Developments Table 110. BCN Peptides SA Company Information Table 111. BCN Peptides SA Business Overview Table 112. BCN Peptides SA Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 113. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 114. BCN Peptides SA Recent Developments Table 115. Amorepacific Corp Company Information Table 116. Amorepacific Corp Business Overview Table 117. Amorepacific Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) & (US$ Million) Table 118. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio Table 119. Amorepacific Corp Recent Developments Table 120. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Image Figure 5. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Type: 2025 VS 2032 Figure 7. DD-04107 Product Figure 8. CMX-020 Product Figure 9. CA-016 Product Figure 10. Others Product Figure 11. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Application: 2025 VS 2032 Figure 13. Abdominal Pain Product Figure 14. Muscle Spasm Product Figure 15. Immunology Product Figure 16. Pruritus Product Figure 17. Ophthalmology Product Figure 18. Others Product Figure 19. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 20. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Region: 2025 VS 2032 Figure 22. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Players in 2025 Figure 23. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Manufacturers Established Date Figure 24. Global Top 5 and 10 Transient Receptor Potential Cation Channel Subfamily V Member 1 Players Market Share by Revenue in 2025 Figure 25. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 28. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 31. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 33. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. U.K. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Netherlands Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Nordic Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 43. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 48. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. China Taiwan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Share by Country (2021-2032) Figure 53. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Colombia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 57. Peru Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 58. Amgen Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 59. Vitality Biopharma Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 60. Toray Industries Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 61. Sylentis SAU Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 62. Pila Pharma AB Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 63. Neurim Pharmaceuticals Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 64. Medifron DBT Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 65. Kyowa Hakko Kirin Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 66. Grunenthal GmbH Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 67. Flex Pharma Inc Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 68. DoNatur GmbH Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 69. Daewoong Pharmaceutical Co Ltd Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 70. Centrexion Therapeutics Corp Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 71. BCN Peptides SA Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026) Figure 72. Amorepacific Corp Revenue Growth Rate in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)

Scope & coverage.

Types
  • DD-04107
  • CMX-020
  • CA-016
  • Others
Applications
  • Abdominal Pain
  • Muscle Spasm
  • Immunology
  • Pruritus
  • Ophthalmology
  • Others
Companies covered
  • Amgen Inc
  • Vitality Biopharma Inc
  • Toray Industries Inc
  • Sylentis SAU
  • Pila Pharma AB
  • Neurim Pharmaceuticals Ltd
  • Medifron DBT Co Ltd
  • Kyowa Hakko Kirin Co Ltd
  • Grunenthal GmbH
  • Flex Pharma Inc
  • DoNatur GmbH
  • Daewoong Pharmaceutical Co Ltd
  • Centrexion Therapeutics Corp
  • BCN Peptides SA
  • Amorepacific Corp

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 DD-04107
  5. 2.2.3 CMX-020
  6. 2.2.4 CA-016
  7. 2.2.5 Others
  8. 2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 by Application
  9. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  10. 2.3.2 Abdominal Pain
  11. 2.3.3 Muscle Spasm
  12. 2.3.4 Immunology
  13. 2.3.5 Pruritus
  14. 2.3.6 Ophthalmology
  15. 2.3.7 Others
  16. 2.4 Assumptions and Limitations
3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by Type
  1. 3.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Type (2021-2026)
  2. 3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Type (2027-2032)
4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Breakdown Data by Application
  1. 4.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Application (2021-2026)
  2. 4.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Perspective (2021-2032)
  2. 5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Growth Trends by Region
  3. 5.2.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Historic Market Size by Region (2021-2026)
  5. 5.2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecasted Market Size by Region (2027-2032)
  6. 5.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Dynamics
  7. 5.3.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Trends
  8. 5.3.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Drivers
  9. 5.3.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Challenges
  10. 5.3.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Revenue
  2. 6.1.1 Global Top Transient Receptor Potential Cation Channel Subfamily V Member 1 Players by Revenue (2021-2026)
  3. 6.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Transient Receptor Potential Cation Channel Subfamily V Member 1 Head Office and Area Served
  6. 6.4 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Players, Product Type & Application
  7. 6.5 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Manufacturers Established Date
  8. 6.6 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  2. 7.2 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  4. 7.4 North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  2. 8.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  4. 8.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  2. 9.2 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  2. 10.2 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  4. 10.4 South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size (2021-2032)
  2. 11.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Amgen Inc
  2. 12.1.1 Amgen Inc Company Information
  3. 12.1.2 Amgen Inc Business Overview
  4. 12.1.3 Amgen Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  5. 12.1.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  6. 12.1.5 Amgen Inc Recent Developments
  7. 12.2 Vitality Biopharma Inc
  8. 12.2.1 Vitality Biopharma Inc Company Information
  9. 12.2.2 Vitality Biopharma Inc Business Overview
  10. 12.2.3 Vitality Biopharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  11. 12.2.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  12. 12.2.5 Vitality Biopharma Inc Recent Developments
  13. 12.3 Toray Industries Inc
  14. 12.3.1 Toray Industries Inc Company Information
  15. 12.3.2 Toray Industries Inc Business Overview
  16. 12.3.3 Toray Industries Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  17. 12.3.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  18. 12.3.5 Toray Industries Inc Recent Developments
  19. 12.4 Sylentis SAU
  20. 12.4.1 Sylentis SAU Company Information
  21. 12.4.2 Sylentis SAU Business Overview
  22. 12.4.3 Sylentis SAU Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  23. 12.4.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  24. 12.4.5 Sylentis SAU Recent Developments
  25. 12.5 Pila Pharma AB
  26. 12.5.1 Pila Pharma AB Company Information
  27. 12.5.2 Pila Pharma AB Business Overview
  28. 12.5.3 Pila Pharma AB Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  29. 12.5.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  30. 12.5.5 Pila Pharma AB Recent Developments
  31. 12.6 Neurim Pharmaceuticals Ltd
  32. 12.6.1 Neurim Pharmaceuticals Ltd Company Information
  33. 12.6.2 Neurim Pharmaceuticals Ltd Business Overview
  34. 12.6.3 Neurim Pharmaceuticals Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  35. 12.6.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  36. 12.6.5 Neurim Pharmaceuticals Ltd Recent Developments
  37. 12.7 Medifron DBT Co Ltd
  38. 12.7.1 Medifron DBT Co Ltd Company Information
  39. 12.7.2 Medifron DBT Co Ltd Business Overview
  40. 12.7.3 Medifron DBT Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  41. 12.7.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  42. 12.7.5 Medifron DBT Co Ltd Recent Developments
  43. 12.8 Kyowa Hakko Kirin Co Ltd
  44. 12.8.1 Kyowa Hakko Kirin Co Ltd Company Information
  45. 12.8.2 Kyowa Hakko Kirin Co Ltd Business Overview
  46. 12.8.3 Kyowa Hakko Kirin Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  47. 12.8.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  48. 12.8.5 Kyowa Hakko Kirin Co Ltd Recent Developments
  49. 12.9 Grunenthal GmbH
  50. 12.9.1 Grunenthal GmbH Company Information
  51. 12.9.2 Grunenthal GmbH Business Overview
  52. 12.9.3 Grunenthal GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  53. 12.9.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  54. 12.9.5 Grunenthal GmbH Recent Developments
  55. 12.10 Flex Pharma Inc
  56. 12.10.1 Flex Pharma Inc Company Information
  57. 12.10.2 Flex Pharma Inc Business Overview
  58. 12.10.3 Flex Pharma Inc Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  59. 12.10.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  60. 12.10.5 Flex Pharma Inc Recent Developments
  61. 12.11 DoNatur GmbH
  62. 12.11.1 DoNatur GmbH Company Information
  63. 12.11.2 DoNatur GmbH Business Overview
  64. 12.11.3 DoNatur GmbH Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  65. 12.11.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  66. 12.11.5 DoNatur GmbH Recent Developments
  67. 12.12 Daewoong Pharmaceutical Co Ltd
  68. 12.12.1 Daewoong Pharmaceutical Co Ltd Company Information
  69. 12.12.2 Daewoong Pharmaceutical Co Ltd Business Overview
  70. 12.12.3 Daewoong Pharmaceutical Co Ltd Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  71. 12.12.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  72. 12.12.5 Daewoong Pharmaceutical Co Ltd Recent Developments
  73. 12.13 Centrexion Therapeutics Corp
  74. 12.13.1 Centrexion Therapeutics Corp Company Information
  75. 12.13.2 Centrexion Therapeutics Corp Business Overview
  76. 12.13.3 Centrexion Therapeutics Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  77. 12.13.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  78. 12.13.5 Centrexion Therapeutics Corp Recent Developments
  79. 12.14 BCN Peptides SA
  80. 12.14.1 BCN Peptides SA Company Information
  81. 12.14.2 BCN Peptides SA Business Overview
  82. 12.14.3 BCN Peptides SA Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  83. 12.14.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  84. 12.14.5 BCN Peptides SA Recent Developments
  85. 12.15 Amorepacific Corp
  86. 12.15.1 Amorepacific Corp Company Information
  87. 12.15.2 Amorepacific Corp Business Overview
  88. 12.15.3 Amorepacific Corp Revenue in Transient Receptor Potential Cation Channel Subfamily V Member 1 Business (2021-2026)
  89. 12.15.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio
  90. 12.15.5 Amorepacific Corp Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst